| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |